Literature DB >> 1762073

Effects of endothelin-3 on renal functions.

Y Yamashita1, T Yukimura, K Miura, M Okumura, K Yamamoto.   

Abstract

The effects of L-NGnitroarginine (LNNA), a nitric oxide synthase inhibitor, and ibuprofen, a cyclooxygenase inhibitor, on the renal actions induced by endothelin (ET)-3 were studied in anesthetized dogs. Continuous infusion of ET-3 in a dose of 5 ng/kg/min for 25 min increased both renal blood flow (RBF) and urine flow rate. In dogs given LNNA (75 micrograms/kg/min for 25 min), the RBF decreased after intrarenal administration of ET-3 (5 ng/kg/min). Glomerular filtration rate (GFR) was unchanged throughout the infusion of ET-3, in dogs treated with and without LNNA. In dogs given ibuprofen (12.5 mg/kg i.v.), an initial increase in RBF was evident after initiating infusion of the peptide, to be followed by a gradual reduction in RBF, GFR decreased significantly with ET-3, whereas the degree of reduction in RBF was the same in dogs treated with LNNA. Thus, ET-3 acts as a vasodilatory and diuretic peptide in the dog kidney. Presumably ET-3 enhances the release of nitric oxide and prostaglandins and then renal vasodilation occurs. Although the enhanced production of prostaglandins by ET-3 may be responsible for maintaining GFR, it is not linked to the initial phase of renal vasodilation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762073

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long-Evans rats.

Authors:  N F Rossi
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

2.  Mechanisms of the biphasic responses to endothelin-3 in dog coronary arteries.

Authors:  T Okamura; T Matsumoto; F Ikemoto; N Toda
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.